NT 102
Alternative Names: NT-102Latest Information Update: 28 Feb 2023
At a glance
- Originator Medical University of South Carolina
- Developer Medical University of South Carolina; Neuroene Therapeutics
- Class Antiepileptic drugs; Small molecules; Vitamins
- Mechanism of Action Vitamin K replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Dravet syndrome
- No development reported Epilepsy